BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7900708)

  • 1. Extraskeletal myxoid chondrosarcoma. Long-term experience with chemotherapy.
    Patel SR; Burgess MA; Papadopoulos NE; Linke KA; Benjamin RS
    Am J Clin Oncol; 1995 Apr; 18(2):161-3. PubMed ID: 7900708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myxoid liposarcoma. Experience with chemotherapy.
    Patel SR; Burgess MA; Plager C; Papadopoulos NE; Linke KA; Benjamin RS
    Cancer; 1994 Aug; 74(4):1265-9. PubMed ID: 8055448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myxoid malignant fibrous histiocytoma: experience with chemotherapy.
    Patel SR; Plager C; Papadopoulos NE; Benjamin RS
    Am J Clin Oncol; 1995 Dec; 18(6):528-31. PubMed ID: 8526198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial.
    Stacchiotti S; Ferrari S; Redondo A; Hindi N; Palmerini E; Vaz Salgado MA; Frezza AM; Casali PG; Gutierrez A; Lopez-Pousa A; Grignani G; Italiano A; LeCesne A; Dumont S; Blay JY; Penel N; Bernabeu D; de Alava E; Karanian M; Morosi C; Brich S; Dagrada GP; Vallacchi V; Castelli C; Brenca M; Racanelli D; Maestro R; Collini P; Cruz J; Martin-Broto J
    Lancet Oncol; 2019 Sep; 20(9):1252-1262. PubMed ID: 31331701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal and extraskeletal myxoid chondrosarcoma: a comparative clinicopathologic, ultrastructural, and molecular study.
    Antonescu CR; Argani P; Erlandson RA; Healey JH; Ladanyi M; Huvos AG
    Cancer; 1998 Oct; 83(8):1504-21. PubMed ID: 9781944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extraskeletal myxoid chondrosarcoma: a reappraisal of its morphologic spectrum and prognostic factors based on 117 cases.
    Meis-Kindblom JM; Bergh P; Gunterberg B; Kindblom LG
    Am J Surg Pathol; 1999 Jun; 23(6):636-50. PubMed ID: 10366145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extraskeletal myxoid chondrosarcoma: a retrospective review from 2 referral centers emphasizing long-term outcomes with surgery and chemotherapy.
    Drilon AD; Popat S; Bhuchar G; D'Adamo DR; Keohan ML; Fisher C; Antonescu CR; Singer S; Brennan MF; Judson I; Maki RG
    Cancer; 2008 Dec; 113(12):3364-71. PubMed ID: 18951519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extraskeletal myxoid chondrosarcoma. A clinicopathologic study of ten patients with long-term follow-up.
    Saleh G; Evans HL; Ro JY; Ayala AG
    Cancer; 1992 Dec; 70(12):2827-30. PubMed ID: 1451062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Responses of 109 adult soft tissue sarcoma patients to chemotherapy].
    Qiu MZ; Xu F; Wang SS; Luo HY; Wang F; Li FH; Sun XF; Xu GC; Lin TY; Huang HQ; Jiang WQ; Guan ZZ; Xu RH
    Ai Zheng; 2007 Dec; 26(12):1344-9. PubMed ID: 18076798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extraskeletal myxoid chondrosarcoma: a review of 23 patients treated at a single referral center with long-term follow-up.
    Ogura K; Fujiwara T; Beppu Y; Chuman H; Yoshida A; Kawano H; Kawai A
    Arch Orthop Trauma Surg; 2012 Oct; 132(10):1379-86. PubMed ID: 22678528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment results obtained in metastatic soft-tissue sarcoma with a combination of doxorubicin and dacarbazine or doxorubicin and ifosfamide.
    Weh HJ; Agarwal K; Zornig C; Schwarz R; Dietel M; Hossfeld DK
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S189-93. PubMed ID: 8453696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas.
    DeLaney TF; Spiro IJ; Suit HD; Gebhardt MC; Hornicek FJ; Mankin HJ; Rosenberg AL; Rosenthal DI; Miryousefi F; Ancukiewicz M; Harmon DC
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1117-27. PubMed ID: 12829150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 15-year experience with chemotherapy of patients with paraganglioma.
    Patel SR; Winchester DJ; Benjamin RS
    Cancer; 1995 Oct; 76(8):1476-80. PubMed ID: 8620426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative chemotherapy for soft-tissue sarcomas of the extremities.
    Pezzi CM; Pollock RE; Evans HL; Lorigan JG; Pezzi TA; Benjamin RS; Romsdahl MM
    Ann Surg; 1990 Apr; 211(4):476-81. PubMed ID: 2157378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
    Bramwell V; Rouesse J; Steward W; Santoro A; Schraffordt-Koops H; Buesa J; Ruka W; Priario J; Wagener T; Burgers M
    J Clin Oncol; 1994 Jun; 12(6):1137-49. PubMed ID: 8201375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytopathology of extraskeletal myxoid chondrosarcoma: report of 8 cases.
    Jakowski JD; Wakely PE
    Cancer; 2007 Oct; 111(5):298-305. PubMed ID: 17676582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative and postoperative adjuvant combination chemotherapy for adults with high grade soft tissue sarcoma.
    Casper ES; Gaynor JJ; Harrison LB; Panicek DM; Hajdu SI; Brennan MF
    Cancer; 1994 Mar; 73(6):1644-51. PubMed ID: 8156491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical outcomes of extraskeletal myxoid chondrosarcoma.
    Ulucaköy C; Atalay İB; Yapar A; Kaptan AY; Bingöl İ; Doğan M; Ekşioğlu MF
    Turk J Med Sci; 2022 Aug; 52(4):1183-1189. PubMed ID: 36326382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of lenograstim on hematologic tolerance to MAID chemotherapy in patients with advanced soft tissue sarcoma and consequences on treatment dose-intensity.
    Bui BN; Chevallier B; Chevreau C; Krakowski I; Peny AM; Thyss A; Maugard-Louboutin C; Cupissol D; Fargeot P; Bonichon F
    J Clin Oncol; 1995 Oct; 13(10):2629-36. PubMed ID: 7595717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination chemotherapy using adriamycin, DTIC, cyclophosphamide, and actinomycin D for advanced soft tissue sarcomas: a randomized comparative trial. A phase III, Southwest Oncology Group Study (7613).
    Baker LH; Frank J; Fine G; Balcerzak SP; Stephens RL; Stuckey WJ; Rivkin S; Saiki J; Ward JH
    J Clin Oncol; 1987 Jun; 5(6):851-61. PubMed ID: 3295129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.